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ABSTRACT 
The prophylactic effect of ethanolic extract of 
Alstonia boonei(AB) stem bark on(2,2-dichlorovinyl 
dimethyl phosphate)DDVP-induced oxidative damage 
in male albino rats’ liver was investigated. Male 
Wistar rats were divided into control, DDVP and 
treatment groups. In the prophylactic experiment, 
AB, (200 and 400 mg/kg body weight) was 
administered by oral gavage for 21th days before 
exposure to DDVP. Lipid peroxidation (LPO), reduced 
glutathione (GSH) levels, catalase (CAT), glutathione 
peroxidase (GPx) and superoxide dismutase (SOD) 
activities were then determined in the liver and heart 
alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) activities were monitored 
and histological examination was carried out. Results  
indicate  that  DDVP-induced  rats  had significantly  
increased  relative  weight  of  liver  and  heart  when  
compared  to  controls. Treatment with AB at 200 
and 400mg/kg caused a significant reduction in 
relative weight of the organs. In DDVP-induced rats, 
serum ALT and AST activities and levels  of  LPO  were  
increased  whereas  hepatic  and  cardiac  SOD,  CAT  
and  GPx  were significantly decreased. Furthermore, 
histological alteration in the liver and aorta were 
observed in DDVP untreated rats and were 
ameliorated in DDVP-induced treated rats with AB. In 
conclusion, the extract possesses antioxidant and 
hepatoprotective properties that eliminate the 
deleterious effects of toxic metabolites of DDVP. 
 
KEYWORDS: Antioxidant, DDVP; 
hepatoprotective; prophylactic; Alstonia boonei. 
 
 
INTRODUCTION 
ecent studies have showed that increased 
formation of free radicals or reactive oxygen 
species (ROS) contribute to cardiovascular 
disease (CVD) progression1. Generation of large 
amounts of ROS can overwhelm the intracellular 
antioxidant defence, causing lipid peroxidation, 
protein variation and DNA breaks2. Studies showed 
that ROS induced depletion of antioxidants are a 
key reason in developing CVD3.The liver is an 
organ in man and animals responsiblefor 
detoxifying thousands of chemicals from bodies 
every single day and if it cannotrole, toxinsbegins 
Original Research  Article                                                                                 
R 
  
 
651 
 
ISSN NO- 2230 – 7885 
CODEN JPBSCT 
NLM Title: J Pharm Biomed Sci. 
 
      
to build up in the tissues. It aids in digestion and 
removes waste products, worn-out cells from the 
blood and in protein synthesis. The liver is our 
greatest chemical factory, it builds complex 
molecules from simple substances absorbed from 
the digestive tract, it makes bile which aids fat 
digestion and removes toxins through the bowels4. 
But the ability of the liver to perform these rolesis 
by many substances exposed to daily. These 
substances include certain medicinal agents which 
when taken in overdoses and sometimes when 
introduced within therapeutic ranges injures the 
organ5. It is important to understand that with the 
present-day human, so many chemical additives 
and pollutants found in the air, water and food this 
signals to important care after the health of our 
liver6. 
Dichlorvos or 2,2-dichlorovinyl dimethyl 
phosphate (Trade Names: DDVP, Vapona, etc.) is a 
volatile organophosphate, widely used as an 
organo-phosphorus insecticide to control 
household pests, in public health, and protecting 
stored product from insects. Dichlorvos has high to 
extreme acute toxicity from oral or dermal 
exposure, and extreme acute toxicity from 
inhalation. Taking in large doses may cause nausea 
and vomiting, restlessness, sweating, and muscle 
tremors. Large doses may cause coma, inability to 
breathe, and death7. Therefore, these adverse 
effects, the search for natural products with 
hepatoprotective potential and slight side effect 
needed. 
Alstonia  boonei  De  Wild  is  large  deciduous 
evergreen  tree,  usually  up  to  45m tall  and  1.2m 
in diameter, belonging  to  the  family  
Apocynaceae consisting  of  about  40-60  species.  
It  is  a  native  of tropical  and  subtropical  Africa,  
Southeast  Asia, Central  America  and  Australia.    
‘Alstonia’ named after Dr. C. Alston (1685-1760), a 
Professor of Botany at Edinburgh University. It’s 
reported for treatment of malaria, intestinal 
helminthes, rheumatism, muscular pain, insomnia, 
and hypertension.  It contains phytochemicals such 
as saponin, alkaloids, tannins and steroids8,9. In 
folk  medical  practice,  an  infusion  of  the  extract  
of  stem  bark  serves  as  anti-snake  venom  and  
as antidote to some arrows poisons.  Antimalarial 
of  various  fractions  of  the  stem  bark  extract  of 
Alstonia boonei  reported by Bello IS & Iyiola  OA 
10,11 while Odugbemi  TO et al., Idowu  OA and 
collegues, Gbadamosi IT and collegues12,13,14 
confirmed indigenous medicinal usefulness of 
Alstonia boonei  for  malaria  therapeutic  use  in 
Southwestern  part  of  Nigeria. Although, 
medicinal importance of stem bark extract of 
Alstonia boonei in ameliorating some disease 
conditions reported by several authors, however, 
to the best of our knowledge, there is lack of 
information on the effect of this plant on protective 
effect. To carry out further scientific scrutiny on 
this plant, this study designed to evaluate the 
hepatoprotective effect of Alstonia boonei  
ethanolic stem bark extract on DDVP-induced 
toxicity in rats. 
 
METHODS 
CHEMICALS 
Dichlorvos or 2,2-dichlorovinyl dimethyl 
phosphate(Trade Names: DDVP, Vapona, etc.) 
Bought from a local chemist in Ibadan, Nigeria. 
Thiobarbituric acids (TBA) bought from Aldrich 
Chemical Co. (Milwaukee, WI, USA). Glutathione, 
hydrogen peroxide, 5,5’-dithios-bis-2-nitrobenzoic 
acid (DNTB) and Epinephrine bought from Sigma 
Chemical Co., Saint Louis, MOUSA. Trichloroacetic 
acid (TCA) and Thiobarbituric acid (TBA) bought 
from British Drug House (BDH) Chemical Ltd., 
Poole, UK. Other reagents were of analytical grade 
and the purest quality available. 
 
COLLECTION AND EXTRACTION OF ALSTONIA 
BOONEI STEM BARK 
The stem bark of Alstonia boonei collected in Ado-
Ekiti (EkitiState) and authenticated at the 
Department of Plant Science, Ekiti State University 
with herbarium number U.H.A.E 65. The stem bark 
of Alstonia boonei air-dried and crushed into fine 
powder. The powdered part extracted with ethanol 
using maceration and the extract concentrated in 
vacuum at 400C with rotary evaporator and water 
bath to dryness. The yield of the extraction was 
5.01%. 
 
ANIMALS 
Inbred male Sprague Dawley rats (Rattus 
novergicus) weighing between 100-190g bought 
from the animal house of the Department of 
Chemical Sciences, Biochemistry Unit, Afe Babalola 
University, Nigeria. Animals kept in aired cages at 
room temperature (28-30°C) and preserved on 
normal laboratory chow (Ladokun Feeds, Ibadan, 
Nigeria) and water ad libitum.  
 
ETHICAL APPROVAL 
Rats handling and treatments conform to 
guidelines of the National Institute of Health (NIH 
publication 85-23, 1985) for laboratory animal 
care and use. The ethical committee of the Afe 
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Babalola University approved this study. All 
animals in this study follow the institutional 
Animal Ethical Committee according to guidelines 
given by Committee for Control and Supervision of 
Experiments on animals (CPCSEA). 
 
INDUCTION Of EXPERIMENTAL ANIMAL  
DDVP [O,O-dimethyl O-(2, 2-
dichlorovinylphosphate) induced in groups II, III 
and IV. Briefly, DDVP dissolved in distilled water 
and then managed by intravenous injection 
(through tail vein) at a dose of 50 mg/kg body 
weight.     
 
STUDY DESIGN 
Twenty male rats randomly divided into four 
groups of five rats each. Group I served as the 
negative control and accessed to normal rat diet 
and water ad libitum only, Group II served as the 
positive control and given 50mg/kg body weight of 
DDVP. Group, III and IV given 200 mg/kg and 400 
mg/kg body weight of the stem bark extracts after 
exposure to 50mg/kg body weight of DDVP 
respectively.    
 
PREPARATION OF TISSUES  
Rats fasted overnight and sacrificed 24 hours after 
the last dose of drugs. Liver and heart quickly 
removed and washed in ice-cold 1.15% KCl 
solution, dried and weighed. A section of liver and 
aorta samples fixed in 10% formalin for 
histological examination. The remaining parts of 
liver and heart homogenized in 4 volumes of 50 
mM phosphate buffer, pH 7.4 and centrifuged at 
10,000g for 15 minutes to get post-mitochondrial 
supernatant fraction (PMF). All procedures carried 
out at temperature of 0-4°C. 
 
PREPARATION OF SERUM 
Blood collected from the heart of the animals into 
plain centrifuge tubes and allowed to stand for 1 
hour. Serum prepared by centrifugation at 3,000g 
for 15 minutes in a Beckman bench centrifuge. The 
clear supernatant used for estimating serum lipid 
profile and enzymes. 
 
BIOCHEMICAL TESTS 
Protein contents of the samplestested by the 
method of Lowry et al.15 using bovine serum 
albumin as standard. The alanine and aspartate 
amino transferases (ALT and AST) tested by the 
combined methods of Mohun and Cook16 and, 
Reitman and Frankel17. Lipid peroxidation level 
tested by the reaction between 2-thiobarbituric 
acid (TBA) and malondialdehyde (MDA), aproduct 
of lipid peroxides as described by Buege and 
Aust18. The tissue superoxide dismutase (SOD) 
measured by the nitro blue tetrazolium (NBT) 
decrease method of McCord and Fridovich19. 
Catalase (CAT) tested spectrophotometrically by 
measuring the rate of decomposition of hydrogen 
peroxide at 240 nm as described by Aebi[20]. 
Reduced glutathione level measured by the 
method of Beutler et al.21, this method is on 
developing a stable (yellow) color when 5’,5’-
dithiobis-(2-nitrobenzoic acid) (Ellman’s reagent) 
added to sulfhydryl compounds. The chromophoric 
product resulting from Ellman’s reagent with the 
reduced glutathione (2-nitro-5-thiobenzoic acid) 
holds a molar absorption at 412 nm which is 
proportion to the reduced glutathione in the test 
sample. The glutathione peroxidase (GPx) assessed 
by the method of Rotruck et al.22.Glutathione-S-
transferase (GST) determined according to Habig 
et al.23, the principle is on all known GST explain a 
high with 1-chloro-2,4-dinitrobenzene as the 
second substrate. When this substance mixed with 
reduced glutathione, its absorption shifts to a 
longer wavelength 340 nm and increase at this 
wavelength provides a direct measurement of the 
enzymatic reaction. 
 
HISTOPATHOLOGY OF TISSUES 
Tissues fixed in 10% formalin dehydrated in 95% 
ethanol and then cleared in xylene before set in 
paraffin. Sections (about 4 µm) prepared and 
stained with hematoxylin and eosin (H&E) dye, 
and examined under a light microscope by a 
Histopathologist who was ignorant of the 
treatment groups. 
 
STATISTICAL ANALYSIS 
All values expressed as the mean ± S.D. of five 
animals each group. Data analyzed using one-way 
ANOVA followed by the post-hoc Duncan multiple 
range test for analysis of biochemical data using 
SPSS(16.0).Values considered statistically 
significant at p< 0.05. 
 
RESULTS 
Effects of Alstonia boonei stem bark on body 
weight and relative weight of organs of DDVP-
induced toxicity rats 
In table 1, there were significant increases 
(p<0.05) in the relative weight of liver and heart of 
DDVP untreated rats when compared with the 
control, while treatment with ethanolic extract of 
Alstonia boonei stem bark (100 and 200 mg/kg) 
significantly reduced the relative weight of heart 
and liver of DDVP rats to values that were 
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statistically similar (p>0.05) to the control. All 
these changes induced by DDVP intoxication were 
significantly (p < 0.05) restored to near normal 
levels on administration of Alstonia boonei stem 
bark. 
 
Table 1. Changes in the body weight and relative weight of organs of DDVP-induced toxicity rats treated with ethanolic extract of Alstonia 
boonei. 
Treatment Body weight (g) Weight of organs (g) Relative weight of organs (g) 
 
 Initial Final Liver Heart Liver Heart 
Control 100.25±0.21 117.46±5.32 6.35±0.27 0.51±0.02 2.22±0.05
 
0.22±0.04 
DDVP untreated 112.08±1.12 128.10±4.96 5.24±0.60 0.44±0.07 3.35±0.08
* 
0.36±0.01
* 
DDVP + 200mg/kg 121.55±2.23 149.36±7.09 5.71±0.74 0.54±0.05 2.10±0.03
** 
0.28±0.01
** 
DDVP + 400mg/kg 151.02±3.35 176.22±4.99 6.13±0.57 0.59±0.04 2.25±0.05
** 
0.24±0.02
** 
Values are means ± S.E.M. of 5 animals per group, DDVP = at 50mg/kg DDVP Treated = Alstonia booneiat 200mg/kg, DDVP treated = 
Alstonia boonei at 400mg/kg, *significantly different from Control (p< 0.05), ** significantly different from DDVP untreated (p< 0.05).  
EFFECTS OF ALSTONIA BOONEI STEM 
BARKON ANTIOXIDANT PARAMETERS AND 
MARKER ENZYMES IN DDVP-INDUCED 
TOXICITY IN RATS 
Administration of DDVP significantly increased 
(p<0.05) serum, hepatic and cardiac lipid 
peroxidation (LPO) products measured as 
thiobarbituric acid reactive substances 
respectively (Table 2).  However, treatment with 
Alstonia boonei extract completely ameliorated 
DDVP-induced increase in LPO. In DDVP -induced 
rats, the activities of hepatic and cardiac GSH, SOD 
and CAT as well as cardiac GPx decreased 
significantly relative to the control (Table 3).  
Excellent performance of extract at (400 mg/kg) 
reversed the adverse effect of DDVP by 
normalizing this enzymatic antioxidant. Alstonia 
boonei pre-treatment prior to DDVP exposure 
caused a significant increase in GPx activities as 
well as a noticeable increase in GSH level. In DDVP-
induced rats, serum ALT and AST were 
significantly increased (Table 4) relative to the 
control. Treatment with Alstonia boonei before 
DDVP exposure resulted in significant protection 
of the liver and heart, as indicated by reductions in 
the elevated levels of ALT and AST; however, there 
was evidence of amelioration in the treated group. 
 
Table 2. Changes in the levels of lipid peroxidation in DDVP-induced toxicity rats treated with ethanolic extract of Alstonia boonei. 
Treatments LIVER 
(μmol MDA/mg protein) 
HEART 
(μmol MDA/mg protein) 
SERUM 
(μmol MDA/mg protein) 
Control 1.52±0.01 2.05±0.02 2.82±0.08 
DDVP untreated 3.98±0.02
* 
4.15±0.03
* 
3.98±0.06
* 
DDVP + 200mg/kg 1.22±0.03
** 
1.45±0.02
** 
1.78 ±0.04
** 
DDVP + 400mg/kg 1.42±0.01
** 
1.85±0.04
** 
2.56±0.07
** 
Values are means ± S.E.M. of 5 animals per group, DDVP = at 50mg/kg DDVP Treated = Alstonia booneiat 200mg/kg, DDVP treated = 
Alstonia boonei at 400mg/kg, *significantly different from control (p< 0.05), ** significantly different from DDVP untreated (p< 0.05). 
Table 3. Changes in the levels of hepatic and cardiac antioxidant parameters in DDVP-induced rats treated with ethanolic extract of 
Alstonia boonei. 
Treatment Liver Heart 
 
GSH       GPx 
(mg /g tissue) 
SOD      CAT 
(U/mg protein) 
GSH     GPx 
(mg /g tissue) 
SOD          CAT 
(U/mg protein) 
Control 25.85±0.15 35.55±0.83 37.36±1.01 35.57±1.08 36.06±1.11 45.74±5.74 57.03±0.01 9.37±0.81 
DDVP 
untreated 
11.23±0.21* 13.65±0.41* 16.23±0.68* 19.22±0.58* 20.21±1.41* 22.26±1.10* 20.26±0.71* 4.57±0.31* 
DDVP + 
200mg/kg 
21.38±0.24** 34.58±0.45** 35.88±0.03** 32.59±0.41** 34.23±2.14** 38.56±1.44** 54.16±0.37** 7.12±0.36** 
DDVP + 
400mg/kg 
24.21±0.27** 35.48±0.21** 36.34±1.00** 34.78±0.81** 35.76±1.32** 42.54±1.22** 56.85±0.21** 8.98±0.47** 
Values are means ± S.E.M. of 5 animals per group, DDVP = at 50mg/kg DDVP Treated = Alstonia booneiat 200mg/kg, DDVP treated = 
Alstonia boonei at 400mg/kg, *significantly different from control (p< 0.05), ** significantly different from DDVP untreated (p< 0.05). 
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Table 4. Changes in the activities of serum, hepatic and cardiac alanine and aspartate aminotransferases in DDVP-induced rats treated with 
ethanolic extract of Alstonia boonei. 
Treatments 
LIVER 
(U/L) 
HEART 
(U/L) 
SERUM 
(U/L) 
 AST ALT AST ALT AST ALT 
Control 57.80±3.42 48.45±2.29 48.45±0.02 55.56±2.24 4.54±1.77 6.37±1.46 
DDVP untreated 28.04±3.62* 26.78±2.56* 26.22±3.38* 23.24±3.34* 8.39±0.56* 9.89±2.24* 
DDVP + 
200mg/kg 
41.56±2.88** 41.12±1.22** 38.02±2.25** 45.42±2.24** 4.13±1.50** 5.23±1.48** 
DDVP + 
400mg/kg 
55.32±1.34** 46.11±1.05** 45.02±1.45** 52.12±1.12** 4.35±1.42** 6.01±1.58** 
Values are means ± S.E.M. of 5 animals per group, DDVP = at 50mg/kg DDVP Treated = Alstonia booneiat 200mg/kg, DDVP treated = 
Alstonia boonei at 400mg/kg, *significantly different from control (p< 0.05), ** significantly different from DDVP untreated (p< 0.05).  
EFFECTS OF ALSTONIA BOONEISTEM BARK 
ON THE HISTOLOGY OF AORTA AND LIVER 
The histology of liver slide of DDVP untreated rats 
showed marked portal congestion, severe 
periportal cellular infiltration by mononuclear 
cells and mild diffuse vacuolar degeneration of 
hepatocytes (Fig. 1). The aorta from DDVP-induced 
toxicity rats revealed large focal area of myofibril 
necrosis with severe hemorrhages and fibrous 
connective tissue laid down (Fig. 2). Treatment 
with Alstonia boonei stem bark extract (200 and 
400mg/kg) reversed the adverse effect of DDVP-
induced toxicity on the histological architecture of 
the aorta and liver of the rats, which is similar to 
their control. The histological results further 
corroborated the biochemical findings suggesting 
the useful effects of Alstonia boonei in DDVP 
induced-toxicity in rats. 
 
 
Control  
DDVP untreated 
 
DDVP + A. boonei(200mg/kg) 
 
DDVP + A. boonei(400mg/kg) 
Figure 1.Changes in histology of liver samples of DDVP-induced toxicity in rats treated with Alstonia boonei ethanolic stem bark extract. 
 
Black arrows show portal congestion, periportal cellular infiltration and vacuolar degeneration of hepatocytes.  
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Control 
 
DDVP untreated 
 
DDVP + A. boonei(200mg/kg) 
 
DDVP + A. boonei(400mg/kg) 
Figure 2.Changes in histology of aorta from DDVP-induced toxicity in rats treated with Alstonia boonei ethanolic stem bark extract. 
 
DISCUSSION 
The present decade has witnessed a great and 
intense resurgence in the interest and use of the 
plant24. The healing power of herbs identified and 
botanical medicine has been one of the oldest 
practiced professions by humanity25. In fact, the 
use of synthetic pharmaceutical products and 
hepatotoxic agent reported not only to connect or 
some serious adverse effects but these drugs are 
costly and not within the reach of all. However, 
traditional use of herbs to promote healing is not 
an alien in any continent. The present examine the 
hepatotoxic effects of the stem bark extract of A. 
boonei.26 reported the therapeutic importance of 
the extract of the stem bark of A. boonei in folk 
medicine. Apart from the lack of information about 
the adverse or toxicity of this plant extract despite 
its wide spread use in folk medicinal or traditional 
practice, there is lack of information underlying 
biochemical mechanism responsible for some of 
the observable and reported properties of this 
plant. The results of the present study suggest that 
mean body weight of DDVP untreated group 
decreased with the increase in relative liver 
weight, agrees with the findings27. However, 
treatment with A. boonei (100 and 200 mg/kg) 
significantly decrease the relative weight of liver 
and heart of the DDVP induced rats. 
Oxidative stress, defined as a disruption of the 
balance between oxidative and antioxidative28. 
Studies in animal models and human clinical trials 
have proved a between lipid peroxidation and 
hepatic damage29. Our results show increased 
levels of MDA in the serum and tissues of DDVP 
induced rats when compared to controls. On the 
other hand, treatment with A. boonei caused a 
significant decrease in the levels of MDA in these 
organs. This protective effect is on the antioxidant 
of A. boonei, which reduced the oxidative damage 
by blocking free radicals produce, and thus 
inhibited lipid peroxidation. The first metabolite of 
DDVP; dichloroacetaldehyde free radical, is 
believed to initiate the biochemical processes 
leading to oxidative stress, which is the direct 
cause of many pathological conditions such as 
diabetes mellitus, cancer, hypertension, kidney 
damage, liver damage  and  death30.  These  
activated  radicals  bind  to micromolecules  and  
reduce  lipids  peroxidative  degradation  of 
polyunsaturated fatty acids. This leads to the 
formation of lipid peroxides  which  in  turn  gives  
products  like  malonylaldehyde that  cause  
damage  to  membranes 31. This lipid peroxidative 
  
 
656 
 
ISSN NO- 2230 – 7885 
CODEN JPBSCT 
NLM Title: J Pharm Biomed Sci. 
 
      
degradation of biomembranes is one of the main 
causes of hepatotoxicity by DDVP. This is usually 
evidenced by a rise in theserum marker enzymes 
of the liver and heart namely AST and ALT. SOD 
and CAT are considered primary antioxidant 
enzymes, since they are involved in direct 
elimination of ROMs32. Effect of DDVP in LPO, CAT 
and SOD activities was found to be tissue 
dependent. In spite of decreased liver and cardiac 
CAT and SOD activities in DDVP rats, increase in 
LPO was observed. Higher LPO and low SOD and 
CAT activity indicates an oxidative stress 
condition. The effect on LPO, CAT, and SOD was 
reversed by A. boonei extract treatments. The 
observation suggests that in order to overcome the 
oxidative damage in liver and heart, some other 
compensatory mechanisms exist in addition to 
antioxidant enzymes. Reversal of decreased 
enzymes and inhibition of LPO appears to be due 
to free radical scavenger activity of ethanol extract 
of A. boonei stem bark in liver and heart. The 
experimental results indicated that LPO played a 
role in tissue injury in DDVP-induced toxicity in 
rats. Ethanol extract of A. boonei stem reduced the 
LPO in liver and, thus effectively protected cell 
functions and structure. The results indicate that 
ethanolic extract of A. boonei stem bark showed 
significant protection against the oxidative damage 
induced by DDVP in liver and heart of rats. A. 
boonei stem bark may act as cardio-protective and 
free radical scavenger agent. 
Glutathione is the strong nucleophilic molecules 
found in most cells with its function as an 
antioxidant. Free radicals are usually destroyed by 
GSH. DDVP may be determined by increasing the 
release of cellular transaminases, increasing the 
production of MDA and decreasing cellular level 
ofGSH33-35. Histopthological  studies  showed  
normal  integrity  of  the  liver and aorta in  the  
control  group.  The liver and heart of rats given 
DDVP, showed severe congestion, necrosis, 
calcification of hepatocytes, mononuclear cell 
infiltration, with areas of vacoulation and 
interstitial hemorrhage; while rats treated with 
200 and 400 mg/kg body weight of the ethanol 
extract of Alstonia boonei plus DDVP shows 
minimal blood congestion, reduction in steatosis, 
fatty degeneration and peripheral hyalinazation of 
the hepatocytes of the liver tissue. This adds 
credence that physiologic recovery preceded 
obvious histological changes and the results may 
suggest that diets supplemented with Alstonia 
boonei will improve hepatic-protection against 
oxidative liver damage. 
CONCLUSION 
In conclusion, the results of the present study 
indicate that Alstonia boonei possess antioxidant 
and hepatoprotective properties, eliminating the 
deleterious effects of toxic metabolites from DDVP 
when administered orally. Further studies are 
required to identify the active component(s) and 
mechanism(s) underlying the beneficial effects of 
this plant.   
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